Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA.

Tillmanns J, Widera C, Habbaba Y, Galuppo P, Kempf T, Wollert KC, Bauersachs J.

Int J Cardiol. 2013 Oct 9;168(4):3926-31. doi: 10.1016/j.ijcard.2013.06.061. Epub 2013 Aug 6.

PMID:
23932048
2.

A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.

Dong M, Liao JK, Yan B, Li R, Zhang M, Yu CM.

Int J Cardiol. 2013 Sep 10;167(6):2813-9. doi: 10.1016/j.ijcard.2012.07.007. Epub 2012 Aug 24.

3.

Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.

Reiser H, Klingenberg R, Hof D, Cooksley-Decasper S, Fuchs N, Akhmedov A, Zoller S, Marques-Vidal P, Marti Soler H, Heg D, Landmesser U, Rodondi N, Mach F, Windecker S, Vollenweider P, Matter CM, Lüscher TF, von Eckardstein A, Gawinecka J.

Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1872-9. doi: 10.1161/ATVBAHA.115.305365. Epub 2015 Jun 11.

4.

Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.

Scirica BM, Sabatine MS, Jarolim P, Murphy SA, de Lemos JL, Braunwald E, Morrow DA.

Eur Heart J. 2011 Mar;32(6):697-705. doi: 10.1093/eurheartj/ehq468. Epub 2010 Dec 22.

PMID:
21183500
5.

Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.

Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.

J Am Coll Cardiol. 2009 Jul 21;54(4):357-64. doi: 10.1016/j.jacc.2009.03.056.

6.

Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.

Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T.

Am Heart J. 2013 May;165(5):716-24. doi: 10.1016/j.ahj.2013.02.008. Epub 2013 Mar 26.

PMID:
23622908
7.

Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.

Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.

Indian Heart J. 2008 Nov-Dec;60(6):536-42.

PMID:
19276492
8.
9.

Prognostic performance of kinetic changes of high-sensitivity troponin T in acute coronary syndrome and in patients with increased troponin without acute coronary syndrome.

Mueller M, Biener M, Vafaie M, Blankenberg S, White HD, Katus HA, Giannitsis E.

Int J Cardiol. 2014 Jul 1;174(3):524-9. doi: 10.1016/j.ijcard.2014.04.110. Epub 2014 Apr 18.

PMID:
24814895
10.

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome.

Bohula May EA, Bonaca MP, Jarolim P, Antman EM, Braunwald E, Giugliano RP, Newby LK, Sabatine MS, Morrow DA.

Clin Chem. 2014 Jan;60(1):158-64. doi: 10.1373/clinchem.2013.206441. Epub 2013 Sep 19.

11.

Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.

Ranjith N, Pegoraro RJ, Naidoo DP, Esterhuizen TM.

Cardiovasc J S Afr. 2006 Mar-Apr;17(2):60-6.

12.

N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.

Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.

J Am Coll Cardiol. 2008 Mar 25;51(12):1188-95. doi: 10.1016/j.jacc.2007.11.054.

13.

A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.

Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY.

J Intern Med. 2007 Dec;262(6):651-8. Epub 2007 Nov 7.

14.

Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).

Lim P, Moutereau S, Simon T, Gallet R, Probst V, Ferrieres J, Gueret P, Danchin N.

Am J Cardiol. 2013 Jan 1;111(1):31-7. doi: 10.1016/j.amjcard.2012.08.042. Epub 2012 Oct 9.

PMID:
23062316
15.

Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI.

Tillmanns J, Fraccarollo D, Galuppo P, Wollert KC, Bauersachs J.

Int J Cardiol. 2017 Apr 1;232:155-159. doi: 10.1016/j.ijcard.2017.01.037. Epub 2017 Jan 5.

PMID:
28082091
16.

Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy.

Celik S, Giannitsis E, Wollert KC, Schwöbel K, Lossnitzer D, Hilbel T, Lehrke S, Zdunek D, Hess A, Januzzi JL, Katus HA.

Clin Res Cardiol. 2011 Dec;100(12):1077-85. doi: 10.1007/s00392-011-0344-x. Epub 2011 Jul 27.

PMID:
21792561
17.

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.

Wallentin L, Lindholm D, Siegbahn A, Wernroth L, Becker RC, Cannon CP, Cornel JH, Himmelmann A, Giannitsis E, Harrington RA, Held C, Husted S, Katus HA, Mahaffey KW, Steg PG, Storey RF, James SK; PLATO study group.

Circulation. 2014 Jan 21;129(3):293-303. doi: 10.1161/CIRCULATIONAHA.113.004420. Epub 2013 Oct 29.

18.

Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes.

De Servi S, Mariani G, Piatti L, Leoncini M, Rubartelli P, Pitì A, Curello S, Galdangelo F, Vandoni P, Rossetti E, Mariani M, Boschetti E, Re G, Loznicker M.

J Cardiovasc Med (Hagerstown). 2014 Jan;15(1):42-7. doi: 10.2459/JCM.0b013e328365a275.

PMID:
24492354
19.

N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.

Windhausen F, Hirsch A, Sanders GT, Cornel J, Fischer J, van Straalen JP, Tijssen JG, Verheugt FW, de Winter RJ; Invasive versus Conservative Treatment in Unstable coronary Syndromes investigators.

Am Heart J. 2007 Apr;153(4):485-92.

PMID:
17383283
20.

Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome.

Mueller M, Biener M, Vafaie M, Doerr S, Keller T, Blankenberg S, Katus HA, Giannitsis E.

Clin Chem. 2012 Jan;58(1):209-18. doi: 10.1373/clinchem.2011.171827. Epub 2011 Dec 1.

Supplemental Content

Support Center